Oncolys BioPharma Inc.TSE 4588

オンコリスバイオファーマ株式会社 · Pharmaceutical · FY ends Dec

Share price at FY-end
—
FY ending Dec 2025
Market cap at FY-end
—
Dividend per share
—
Avg. director pay
¥41.6M
Internal directors

Top 10 shareholders

#ShareholderSharesStakeValueDividends
1 アステラス製薬株式会社 727,200 2.48% — —
2 モルガン・スタンレーMUFG証券株式会社 653,700 2.23% — —
3 浦田 泰生 520,700 1.77% — —
4 YUANTA SECURITIES CO., LTD-RETAIL ACCOUNT 388,400 1.32% — —
5 西田 博行 300,000 1.02% — —
6 株式会社SBI証券 287,714 0.98% — —
7 今村 均 272,200 0.92% — —
8 野村證券株式会社
Asset-management company of 野村 浩子
271,670 0.92% — —
9 UBS証券株式会社 267,454 0.91% — —
10 中西 均 255,100 0.87% — —

Officers' holdings and pay

NameTitleSharesValuePay
浦田 泰生 President & Representative Director 520,700 — —
樫原 康成 Managing Director 133,000 — —
原野 修 Director — — —
斎藤 泰 Director — — —
飯野 直子 Director — — —
久世 愼一 Audit & Supervisory Board Member — — —
栁澤 崇仁 Audit & Supervisory Board Member — — —
永末 真也 Audit & Supervisory Board Member — — —

Pay is shown only for officers whose pay of ¥100 million or more is disclosed individually.

Per-share data by fiscal year

Fiscal yearPriceEPSP/EDividendShares issued
FY ending Dec 2025 — ¥-80.00 — — 29,291,600
FY ending Dec 2024 — ¥-77.17 — — 24,961,600
FY ending Dec 2023 — ¥-108.92 — — 19,717,100
Source: annual securities reports on EDINET. Values are estimates. Methodology